Abstract
Aim:
To investigate the effects of renal ischemic preconditioning (IPC) on both renal hemodynamics and the renal interstitial concentrations of adenosine and adenine nucleotides induced by ischemia-reperfusion injury.
Methods:
Renal hemodynamics responses to ischemia-reperfusion injury in mongrel dog models were determined with or without multiple brief renal ischemic preconditioning treatments, as well as the adenosine A1 receptor antagonist (KW-3902), respectively. The renal interstitial concentrations of adenosine and adenine nucleotides in response to ischemia-reperfusion injury, either following 1–3 cycles of IPC or not, were measured simultaneously using microdialysis sampling technology.
Results:
One 10-min IPC, adenosine A1 receptor antagonist (KW-3902) also shortened the recovery time of renal blood flow (RBF) and urine flow (UF), as well as mean blood pressure (BP). Advanced renal IPC attenuated the increment of adenosine and adenine nucleotides, as well as recovery time during the 60-min reperfusion which followed the 60-min renal ischemia. All of these recovery times were dependent on the cycles of 10-min IPC. The renal interstitial concentrations of adenosine and adenine nucleotides increased and decreased during renal ischemia and reperfusion, respectively.
Conclusion:
A significant relativity in dog models exists between the cycles of 10-min renal IPC and the recovery time of BP, UF, and RBF during the 60-min renal reperfusion following 60-min renal ischemia, respectively. Renal IPC can protect against ischemia-reperfusion injury and the predominant effect of endogenous adenosine induced by prolonged renal ischemia; renal adenosine A1 receptor activation during the renal ischemia-reperfusion injury is detrimental to renal function.
Similar content being viewed by others
Article PDF
References
Kerrigan CL, Stotland MA . Ischemia reperfusion injury: a review. Microsurgery 1993; 14: 165–75.
Aronson S, Blumenthal R . Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothorac Vasc Anesth 1998; 12: 567–86.
Huet F, Gouyou JB, Guignard JP . Prevention of hypoxemia-induced renal dysfunction by perindoprilat in the rabbit. Life Sci 1997; 61: 2157–65.
Lee HT, Emala CW . Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors. Am J Physiol Renal Physiol 2000; 278: F380–7.
Nishiyama A, Miyatake A, Aki Y, Fukui T, Rahman M, Kimura S, et al. Adenosine A1 receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction. J Pharmacol Exp Ther 1999; 291: 988–93.
Meldrum DR . Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning. J Surg Res 1997; 73: 1–13.
Reimer KA, Jennings RB . Ischemic preconditioning: a brief review. Basic Res Cardiol 1996; 91: 1–4.
Islam CF, Mathie RT, Dinneen MD, Kiely EA, Peters AM, Grace PA . Ischaemia-reperfusion injury in the rat kidney: the effect of preconditioning. Br J Urol 1997; 79: 842–7.
Turman MA, Bates CM . Susceptibility of human proximal tubular cells to hypoxia: effect of hypoxic preconditioning and comparison to glomerular cells. Ren Fail 1997; 19: 47–60.
Sugino H, Shimada H, Tsuchimoto K . Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats. Jpn J Pharmacol 2001; 87: 134–42.
Nishiyama A, Kimura S, He H, Miura K, Rahman M, Fujisawa Y, et al. Renal interstitial adenosine metabolism during ischemia in dogs. Am J Physiol Renal Physiol 2001; 280: F231–8.
Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD . Paracrine regulation of the renal microcirculation. Physiol Rev 1996; 76: 425–536.
Spielman WS, Arend LJ . Adenosine receptors and signaling in the kidney. Hypertension 1991; 17: 117–30.
Spielman WS, Thompson CI . A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol 1982; 242: F423–35.
Lin JJ, Churchill PC, Bidani AK . Effect of theophylline on the initiation phase of postischemic acute renal failure in rats. J Lab Clin Med 1986; 108: 150–4.
Lin JJ, Churchill PC, Bidani AK . The effect of dipyridamole on the initiation phase of postischemic acute renal failure in rats. Can J Physiol Pharmacol 1987; 65: 1491–5.
Lin JJ, Churchill PC, Bidani AK . Theophylline in rats during maintenance phase of post-ischemic acute renal failure. Kidney Int 1988; 33: 24–8.
Rahman M, Kimura S, Yoneyama H, Kasaka H, Nishiyama A, Fukui T, et al. Effects of furosemide on the tubular reabsorption of nitrates in anesthetized dogs. Eur J Pharmacol 2001; 428: 113–9.
Nishiyama A, Miyatake A, Kusudo K, Syokoji T, Yue W, Fukui T, et al. Effects of halothane on renal hemodynamics and interstitial nitric oxide in rabbits. Eur J Pharmacol 1999; 367: 299–306.
Miura K, Okumura M, Yukimura T, Yamamoto K . Fluorometric determination of plasma adenosine concentrations using high-performance liquid chromatography. Anal Biochem 1991; 196: 84–8.
Ogawa T, Mimura Y, Kaminishi M . Renal denervation abolishes the protective effects of ischaemic preconditioning on function and haemodynamics in ischaemia-reperfused rat kidneys. Acta Physiol Scand 2002; 174: 291–7.
Murry CE, Jennings RB, Reimer KA . Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124–36.
Zager RA, Jurkowitz MS, Merola AJ . Responses of the normal rat kidney to sequential ischemic events. Am J Physiol 1985; 249: F148–59.
Riera M, Herrero J, Torras J, Cruzado JM, Fatjo M, Lloberas N, et al. Ischemic preconditioning improves postischemic acute renal failure. Transplant Proc 1999; 31: 2346–7.
Cochrane J, Williams BT, Banerjee A, Harken AH, Burke TJ, Cairns CB, et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Ren Fail 1999; 21: 135–45.
Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM . Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350–6.
Thornton JD, Liu GS, Olsson RA, Downey JM . Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659–65.
Rossi N, Ellis V, Kontry T, Gunther S, Churchill P, Bidani A . The role of adenosine in HgCl2-induced acute renal failure in rats. Am J Physiol 1990; 258: F1554–60.
Agmon Y, Dinour D, Brezis M . Disparate effects of adenosine A1- and A2-receptor agonists on intrarenal blood flow. Am J Physiol 1993; 265: F802–6.
Spielman WS, Osswald H . Blockade of postocclusive renal vasoconstriction by an angiotensin II antagonists: evidence for an angiotensin-adenosine interaction. Am J Physiol 1979; 237: F463–7.
Nishiyama A, Miura K, Miyatake A, Fujisawa Y, Yue W, Fukui T, et al. Renal interstitial concentration of adenosine during endotoxin shock. Eur J Pharmacol 1999; 385: 209–16.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported in part by the National Natural Science Foundation of China (No 30371781) and a grant-in-aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
Rights and permissions
About this article
Cite this article
Li, Fz., Kimura, S., Nishiyama, A. et al. Ischemic preconditioning protects post-ischemic renal function in anesthetized dogs: role of adenosine and adenine nucleotides. Acta Pharmacol Sin 26, 851–859 (2005). https://doi.org/10.1111/j.1745-7254.2005.00109.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00109.x
Keywords
This article is cited by
-
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review
Naunyn-Schmiedeberg's Archives of Pharmacology (2007)